Ciliary neurotrophic factor implant (StemCells)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCiliary neurotrophic factor implant (StemCells)
Drug Alias NameCiliary neurotrophic factor implant -CNTF implant -
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCiliary neurotrophic factor replacements
TargetsCiliary neurotrophic factor
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of LausanneMicrobot Medical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMicrobot MedicalUniversity Of Lausanne
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A